SecBot SecBot
144 ·Filed Jun 10, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizonweeks Processed5mo ago SEC0001950047-26-005897
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The repeated insider selling by a key officer is a bearish signal, though the stock has shown resilience. Monitor for additional 144 filings or Form 4 submissions indicating further sales. Consider the pattern as a potential headwind to near-term price appreciation.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$54.24
T+0 close · Jun 10, 2026 · via day close
Latest settled
+4.72%
T+60 · $56.80
Vs SPY
+0.32%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $54.24entry
  2. T+1 · 5mo ago +3.37%α +2.83% · $56.07
  3. T+5 · 5mo ago +4.66%α +4.23% · $56.77
  4. T+20 · 4mo ago +22.77%α +20.88% · $66.59
  5. T+60 · 2mo ago +4.72%α +0.32% · $56.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on June 10, 2026, indicating intent to sell 20,000 shares (~$1.05M). This is part of a heavy selling pattern with over 250,000 shares sold in the past month, representing a significant insider distribution. The sustained selling by a key officer raises caution despite strong analyst consensus.

Key Facts

  • Officer Dennis Mulroy intends to sell 20,000 shares valued at ~$1,046,560.
  • Mulroy has sold over 250,000 shares in the past month (since May 15, 2026), totaling roughly $13M.
  • The 144 filing is for shares acquired via stock option exercise.
  • AnaptysBio has a market cap of $1.5B and 94% analyst bullish rating.

Financial Impact

Officer Dennis Mulroy proposes to sell 20,000 shares worth ~$1.05M, part of a selling spree totaling over 250,000 shares valued at ~$13M in the past month (May 15, June 10, 2026).

dilutioninsider selling volume

Risk Factors

  • Continued insider selling could signal management's lack of confidence ahead of upcoming catalysts or earnings.
  • The selling volume may create technical overhang, especially if open-market sales persist.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005897
Document: 0001950047-26-005897-index.html0001950047-26-005897
Document: 0001950047-26-005897.txt0001950047-26-005897

Track record

28 reports on ANAB

Performance horizon

10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026